Journal articles on the topic 'Huntington's disease Magnetic resonance imaging'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Huntington's disease Magnetic resonance imaging.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Sethi, Kapil D. "Magnetic resonance imaging in huntington's disease." Movement Disorders 6, no. 2 (1991): 186. http://dx.doi.org/10.1002/mds.870060223.
Full textSingh, Paramdeep, and Rupinderjeet Kaur. "Magnetic resonance imaging findings in case of Huntington's disease." Journal of Clinical Sciences 17, no. 1 (2020): 9. http://dx.doi.org/10.4103/jcls.jcls_46_19.
Full textKlöppel, S., S. M. Henley, N. Z. Hobbs, R. C. Wolf, J. Kassubek, S. J. Tabrizi, and R. S. J. Frackowiak. "Magnetic resonance imaging of Huntington's disease: preparing for clinical trials." Neuroscience 164, no. 1 (November 2009): 205–19. http://dx.doi.org/10.1016/j.neuroscience.2009.01.045.
Full textWolf, Robert Christian, Fabio Sambataro, Nenad Vasic, Nadine Donata Wolf, Philipp Arthur Thomann, G. Bernhard Landwehrmeyer, and Michael Orth. "Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's disease." Experimental Neurology 231, no. 2 (October 2011): 214–22. http://dx.doi.org/10.1016/j.expneurol.2011.06.011.
Full textDomínguez, Juan F., Julie C. Stout, Govinda Poudel, Andrew Churchyard, Phyllis Chua, Gary F. Egan, and Nellie Georgiou-Karistianis. "Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data." British Journal of Psychiatry 208, no. 6 (June 2016): 571–78. http://dx.doi.org/10.1192/bjp.bp.114.156588.
Full textBohanna, India, Nellie Georgiou-Karistianis, Anthony J. Hannan, and Gary F. Egan. "Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease." Brain Research Reviews 58, no. 1 (June 2008): 209–25. http://dx.doi.org/10.1016/j.brainresrev.2008.04.001.
Full textStarkstein, S. E., J. Brandt, F. Bylsma, C. Peyser, M. Folstein, and S. E. Folstein. "Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study." Neuroradiology 34, no. 6 (1992): 487–89. http://dx.doi.org/10.1007/bf00598956.
Full textAylward, Elizabeth H. "Magnetic resonance imaging striatal volumes: A biomarker for clinical trials in Huntington's disease." Movement Disorders 29, no. 11 (August 27, 2014): 1429–33. http://dx.doi.org/10.1002/mds.26013.
Full textWolf, Robert C., Georg Grön, Fabio Sambataro, Nenad Vasic, Nadine D. Wolf, Philipp A. Thomann, Carsten Saft, G. Bernhard Landwehrmeyer, and Michael Orth. "Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease." Journal of Cerebral Blood Flow & Metabolism 31, no. 9 (May 11, 2011): 1908–18. http://dx.doi.org/10.1038/jcbfm.2011.60.
Full textHarris, Gordon J., Godfrey D. Pearlson, Carol E. Peyser, Elizabeth H. Aylward, Joy Roberts, Patrick E. Barta, Gary A. Chase, and Susan E. Folstein. "Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease." Annals of Neurology 31, no. 1 (January 1992): 69–75. http://dx.doi.org/10.1002/ana.410310113.
Full textPuri, BK, GM Bydder, MS Manku, A. Clarke, AD Waldman, and CF Beckmann. "Reduction in Cerebral Atrophy Associated with Ethyl-Eicosapentaenoic Acid Treatment in Patients with Huntington's Disease." Journal of International Medical Research 36, no. 5 (October 2008): 896–905. http://dx.doi.org/10.1177/147323000803600505.
Full textZacharoff, Lori, Ivan Tkac, Qingfeng Song, Chuanning Tang, Patrick J. Bolan, Silvia Mangia, Pierre-Gilles Henry, Tongbin Li, and Janet M. Dubinsky. "Cortical Metabolites as Biomarkers in the R6/2 Model of Huntington's Disease." Journal of Cerebral Blood Flow & Metabolism 32, no. 3 (November 2, 2011): 502–14. http://dx.doi.org/10.1038/jcbfm.2011.157.
Full textFeki, Fatma, Chahnez Triki, and Nesrine Amara. "Drug-Resistant Myoclonic Epilepsy Revealing Juvenile Huntington's Disease: A Case Report." Journal of Pediatric Epilepsy 07, no. 01 (March 2018): 021–23. http://dx.doi.org/10.1055/s-0038-1641727.
Full textGeorgiou-Karistianis, N., S.-P. Carron, I. Bohanna, J. C. Stout, A. Churchyard, P. Chua, E. Frajman, and G. Egan. "I07 Image-HD: a functional magnetic resonance imaging study of spatial working memory in Huntington's disease." Journal of Neurology, Neurosurgery & Psychiatry 81, Suppl 1 (September 2010): A38.1—A38. http://dx.doi.org/10.1136/jnnp.2010.222679.7.
Full textSánchez-Castañeda, Cristina, Ferdinando Squitieri, Margherita Di Paola, Michael Dayan, Martina Petrollini, and Umberto Sabatini. "The role of iron in gray matter degeneration in Huntington's disease: A magnetic resonance imaging study." Human Brain Mapping 36, no. 1 (August 21, 2014): 50–66. http://dx.doi.org/10.1002/hbm.22612.
Full textSarac, H., and S. Telarovic. "Magnetic resonance imaging and proton spectroscopy in the Huntington disease." Journal of the Neurological Sciences 333 (October 2013): e125. http://dx.doi.org/10.1016/j.jns.2013.07.418.
Full textLeitão, Ricardo, Carla Guerreiro, Rita G. Nunes, Nilza Gonçalves, Giulia Galati, Madalena Rosário, Leonor Correia Guedes, Joaquim J. Ferreira, and Sofia Reimão. "Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington’s Disease." Journal of Huntington's Disease 9, no. 2 (June 5, 2020): 143–48. http://dx.doi.org/10.3233/jhd-190388.
Full textSawiak, S. J., N. I. Wood, G. B. Williams, A. J. Morton, and T. A. Carpenter. "Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease." Neurobiology of Disease 33, no. 1 (January 2009): 12–19. http://dx.doi.org/10.1016/j.nbd.2008.09.017.
Full textGavazzi, Cinzia, Riccardo Della Nave, Raffaele Petralli, Maria Assunta Rocca, Laura Guerrini, Carlo Tessa, Stefano Diciotti, Massimo Filippi, Silvia Piacentini, and Mario Mascalchi. "Combining Functional and Structural Brain Magnetic Resonance Imaging in Huntington Disease." Journal of Computer Assisted Tomography 31, no. 4 (July 2007): 574–80. http://dx.doi.org/10.1097/01.rct.0000284390.53202.2e.
Full textAggarwal, Manisha, Wenzhen Duan, Zhipeng Hou, Neal Rakesh, Qi Peng, Christopher A. Ross, Michael I. Miller, Susumu Mori, and Jiangyang Zhang. "Spatiotemporal mapping of brain atrophy in mouse models of Huntington's disease using longitudinal in vivo magnetic resonance imaging." NeuroImage 60, no. 4 (May 2012): 2086–95. http://dx.doi.org/10.1016/j.neuroimage.2012.01.141.
Full textHarris, G. J., E. H. Aylward, C. E. Peyser, G. D. Pearlson, J. Brandt, J. V. Roberts-Twillie, P. E. Barta, and S. E. Folstein. "Single Photon Emission Computed Tomographic Blood Flow and Magnetic Resonance Volume Imaging of Basal Ganglia in Huntington's Disease." Archives of Neurology 53, no. 4 (April 1, 1996): 316–24. http://dx.doi.org/10.1001/archneur.1996.00550040044013.
Full textGeorgiou-Karistianis, Nellie, Julie C. Stout, Juan F. Domínguez D., Sarah P. Carron, Ayaka Ando, Andrew Churchyard, Phyllis Chua, et al. "Functional magnetic resonance imaging of working memory in Huntington's disease: Cross-sectional data from the IMAGE-HD study." Human Brain Mapping 35, no. 5 (August 2, 2013): 1847–64. http://dx.doi.org/10.1002/hbm.22296.
Full textCui, Weitong, Wei Fu, Yunfeng Lin, and Tianxu Zhang. "Application of Nanomaterials in Neurodegenerative Diseases." Current Stem Cell Research & Therapy 16, no. 1 (December 1, 2021): 83–94. http://dx.doi.org/10.2174/1574888x15666200326093410.
Full textMoraes, Louise, Andreia Vasconcelos-dos-Santos, Fernando Cleber Santana, Mariana Araya Godoy, Paulo Henrique Rosado-de-Castro, Jasmin, Ricardo Luiz Azevedo-Pereira, et al. "Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease." Stem Cell Research 9, no. 2 (September 2012): 143–55. http://dx.doi.org/10.1016/j.scr.2012.05.005.
Full textSeliverstov, Yu A., E. V. Seliverstova, R. N. Konovalov, S. A. Klyushnikov, M. V. Krotenkova, and S. N. Illarioshkin. "CLINICAL AND IMAGING ANALYSIS OF HUNTINGTON DISEASE WITH USE OF RESTING-STATE FUNCTIONAL MAGNETIC RESONANCE IMAGING." Neurological Journal 20, no. 3 (July 29, 2015): 11. http://dx.doi.org/10.18821/1560-9545-2015-20-3-11-21.
Full textWolf, R. C., F. Sambataro, N. Vasic, M. S. Depping, P. A. Thomann, G. B. Landwehrmeyer, S. D. Süssmuth, and M. Orth. "Abnormal resting-state connectivity of motor and cognitive networks in early manifest Huntington's disease." Psychological Medicine 44, no. 15 (March 27, 2014): 3341–56. http://dx.doi.org/10.1017/s0033291714000579.
Full textJenkins, Bruce G., Emmanuel Brouillet, Yin-Ching I. Chen, Elsdon Storey, Jörg B. Schulz, Pamela Kirschner, M. Flint Beal, and Bruce R. Rosen. "Non-Invasive Neurochemical Analysis of Focal Excitotoxic Lesions in Models of Neurodegenerative Illness Using Spectroscopic Imaging." Journal of Cerebral Blood Flow & Metabolism 16, no. 3 (May 1996): 450–61. http://dx.doi.org/10.1097/00004647-199605000-00011.
Full textHedjoudje, Abderrahmane, Gaël Nicolas, Alice Goldenberg, Catherine Vanhulle, Clémentine Dumant-Forrest, Guillaume Deverrière, Pauline Treguier, et al. "Morphological features in juvenile Huntington disease associated with cerebellar atrophy — magnetic resonance imaging morphometric analysis." Pediatric Radiology 48, no. 10 (June 20, 2018): 1463–71. http://dx.doi.org/10.1007/s00247-018-4167-z.
Full textBeste, C., C. Konrad, C. Saft, J. Andrich, R. Gold, B. Pfleiderer, M. Hausmann, and M. Falkenstein. "69. Voluntary movement execution in Huntington’s disease – a combined neurophysiological and morphometric magnetic resonance imaging study." Clinical Neurophysiology 120, no. 1 (January 2009): e31. http://dx.doi.org/10.1016/j.clinph.2008.07.068.
Full textCHUA, P., P. DESMOND, S. CHRISTENSEN, C. STEWARD, D. VELAKOULIS, F. JUDD, E. CHIU, J. LLOYD, and B. TRESS. "Poster 19: Basal Ganglia Pathology in Preclinical and Early Symptomatic Huntington's Disease: Diffusion Tensor Imaging, Magnetic Resonance Spectroscopy, and Volumetric Measures—Which Imaging Modality Is More Sensitive?" Neurotherapeutics 6, no. 1 (January 2009): 210. http://dx.doi.org/10.1016/j.nurt.2008.10.023.
Full textTeichmann, Marc, Emmanuel Dupoux, Sid Kouider, and Anne-Catherine Bachoud-Lévi. "The Role of the Striatum in Processing Language Rules: Evidence from Word Perception in Huntington's Disease." Journal of Cognitive Neuroscience 18, no. 9 (September 2006): 1555–69. http://dx.doi.org/10.1162/jocn.2006.18.9.1555.
Full textAdanyeguh, Isaac M., Marie-Lorraine Monin, Daisy Rinaldi, Léorah Freeman, Alexandra Durr, Stéphane Lehéricy, Pierre-Gilles Henry, and Fanny Mochel. "Expanded neurochemical profile in the early stage of Huntington disease using proton magnetic resonance spectroscopy." NMR in Biomedicine 31, no. 3 (January 9, 2018): e3880. http://dx.doi.org/10.1002/nbm.3880.
Full textSaba, Roberta Arb, James H. Yared, Thomas M. Doring, Med Phys, Vanderci Borges, and Henrique Ballalai Ferraz. "Diffusion tensor imaging of brain white matter in Huntington gene mutation individuals." Arquivos de Neuro-Psiquiatria 75, no. 8 (August 2017): 503–8. http://dx.doi.org/10.1590/0004-282x20170085.
Full textLee, Wang-Tso, and Chen Chang. "Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington’s disease." Progress in Neurobiology 72, no. 2 (February 2004): 87–110. http://dx.doi.org/10.1016/j.pneurobio.2004.02.002.
Full textEvans, A. C., C. Beil, S. Marrett, C. J. Thompson, and A. Hakim. "Anatomical-Functional Correlation Using an Adjustable MRI-Based Region of Interest Atlas with Positron Emission Tomography." Journal of Cerebral Blood Flow & Metabolism 8, no. 4 (August 1988): 513–30. http://dx.doi.org/10.1038/jcbfm.1988.92.
Full textMoeller, Ashley A., Marcia V. Felker, Jennifer A. Brault, Laura C. Duncan, Rizwan Hamid, and Meredith R. Golomb. "Patients With Extreme Early Onset Juvenile Huntington Disease Can Have Delays in Diagnosis: A Case Report and Literature Review." Child Neurology Open 8 (January 2021): 2329048X2110361. http://dx.doi.org/10.1177/2329048x211036137.
Full textGraziola, Federica, Sabrina Maffi, Melissa Grasso, Giacomo Garone, Simone Migliore, Eugenia Scaricamazza, Consuelo Ceccarelli, et al. "“Spazio Huntington”: Tracing the Early Motor, Cognitive and Behavioral Profiles of Kids with Proven Pediatric Huntington Disease and Expanded Mutations > 80 CAG Repeats." Journal of Personalized Medicine 12, no. 1 (January 17, 2022): 120. http://dx.doi.org/10.3390/jpm12010120.
Full textFurukawa, Fumiko, Kinya Ishikawa, Takanori Yokota, and Nobuo Sanjo. "Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington’s Disease." European Neurology 81, no. 1-2 (2019): 13–18. http://dx.doi.org/10.1159/000499909.
Full textByrne, Lauren M., Filipe B. Rodrigues, Eileanor B. Johnson, Peter A. Wijeratne, Enrico De Vita, Daniel C. Alexander, Giuseppe Palermo, et al. "Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease." Science Translational Medicine 10, no. 458 (September 12, 2018): eaat7108. http://dx.doi.org/10.1126/scitranslmed.aat7108.
Full textSimmons, Danielle A., Brian D. Mills, Robert R. Butler III, Jason Kuan, Tyne L. M. McHugh, Carolyn Akers, James Zhou, et al. "Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington’s Disease: Preclinical Evidence with the p75NTR Ligand LM11A-31." Neurotherapeutics 18, no. 2 (March 30, 2021): 1039–63. http://dx.doi.org/10.1007/s13311-021-01023-8.
Full textVallès, Astrid, Melvin M. Evers, Anouk Stam, Marina Sogorb-Gonzalez, Cynthia Brouwers, Carlos Vendrell-Tornero, Seyda Acar-Broekmans, et al. "Widespread and sustained target engagement in Huntington’s disease minipigs upon intrastriatal microRNA-based gene therapy." Science Translational Medicine 13, no. 588 (April 7, 2021): eabb8920. http://dx.doi.org/10.1126/scitranslmed.abb8920.
Full textYu, Ji-Hea, Bae-Geun Nam, Min-Gi Kim, Soonil Pyo, Jung-Hwa Seo, and Sung-Rae Cho. "In Vivo Expression of Reprogramming Factor OCT4 Ameliorates Myelination Deficits and Induces Striatal Neuroprotection in Huntington’s Disease." Genes 12, no. 5 (May 10, 2021): 712. http://dx.doi.org/10.3390/genes12050712.
Full textCasella, Chiara, Jose Bourbon-Teles, Sonya Bells, Elizabeth Coulthard, Greg D. Parker, Anne Rosser, Derek K. Jones, and Claudia Metzler-Baddeley. "Drumming Motor Sequence Training Induces Apparent Myelin Remodelling in Huntington’s Disease: A Longitudinal Diffusion MRI and Quantitative Magnetization Transfer Study." Journal of Huntington's Disease 9, no. 3 (October 8, 2020): 303–20. http://dx.doi.org/10.3233/jhd-200424.
Full textO’Connell, Adam B., Timothy R. Kuchel, Sunthara R. Perumal, Victoria Sherwood, Daniel Neumann, John W. Finnie, Kim M. Hemsley, and A. Jennifer Morton. "Longitudinal Magnetic Resonance Spectroscopy and Diffusion Tensor Imaging in Sheep (Ovis aries) With Quinolinic Acid Lesions of the Striatum: Time-Dependent Recovery of N-Acetylaspartate and Fractional Anisotropy." Journal of Neuropathology & Experimental Neurology 79, no. 10 (August 2, 2020): 1084–92. http://dx.doi.org/10.1093/jnen/nlaa053.
Full textSpronck, Elisabeth, Astrid Vallès, Margit Lampen, Paula Montenegro-Miranda, Sonay Keskin, Liesbeth Heijink, Melvin Evers, et al. "Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease Pathology." Brain Sciences 11, no. 2 (January 20, 2021): 129. http://dx.doi.org/10.3390/brainsci11020129.
Full textKronenbuerger, Martin, Jun Hua, Jee Y. A. Bang, Kia E. Ultz, Xinyuan Miao, Xiaoyu Zhang, James J. Pekar, et al. "Differential Changes in Functional Connectivity of Striatum-Prefrontal and Striatum-Motor Circuits in Premanifest Huntington’s Disease." Neurodegenerative Diseases 19, no. 2 (2019): 78–87. http://dx.doi.org/10.1159/000501616.
Full textHwang, S. U., J. D. Yoon, K. Eun, H. Kim, and S. H. Hyun. "25 PRODUCTION OF TRANSGENIC PIGS WITH CreER-MEDIATED ASTROCYTIC-SPECIFIC RECOMBINATION SYSTEM FOR NEUROLOGICAL DISEASE MODELS." Reproduction, Fertility and Development 29, no. 1 (2017): 120. http://dx.doi.org/10.1071/rdv29n1ab25.
Full textPuri, Basant K. "High-resolution magnetic resonance imaging sinc-interpolation-based subvoxel registration and semi-automated quantitative lateral ventricular morphology employing threshold computation and binary image creation in the study of fatty acid interventions in schizophrenia, depression, chronic fatigue syndrome and Huntington's disease." International Review of Psychiatry 18, no. 2 (January 2006): 149–54. http://dx.doi.org/10.1080/09540260600583015.
Full textSarac, Helena, David Ozretic, Neven Henigsberg, Pero Hrabac, Ivan Bagaric, and Lucija Bagaric-Krakan. "PROTON MAGNETIC RESONANCE SPECTROSCOPY IN HUNTINGTON'S DISEASE ACCOMPANYING NEUROBORRELIOSIS." Psychiatria Danubina 29, no. 2 (June 26, 2017): 226–30. http://dx.doi.org/10.24869/psyd.2017.226.
Full textSturrock, Aaron, Corree Laule, Katy Wyper, Ruth A. Milner, Joji Decolongon, Rachelle Dar Santos, Allison J. Coleman, et al. "A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers." Movement Disorders 30, no. 3 (February 18, 2015): 393–401. http://dx.doi.org/10.1002/mds.26118.
Full text